A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

NCT07340190 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: pelabresib
DRUG: repaglinide
DRUG: midazolam
DRUG: drospirenone
DRUG: ethinyl estradiol

Sponsor

Novartis Pharmaceuticals